Overview
Company Does Not Provide H-1B Sponsorship
BrainEffect creates nutritional supplements and functional foods in Berlin to support mental and physical performance. Its products use science-backed natural ingredients across vitamins, minerals, prebiotics, probiotics, collagen, proteins, and sleep aids, with core offerings like FOCUS, SLEEP, and DAILY GUT that address sleep, gut health, focus, energy, and recovery. It sells through its own online store and more than 2,500 retailers, including dm, Budni, and Amazon; founder Fabian Foelsch remains CEO, and Schwabe Group owns a majority stake but BrainEffect operates independently. The goal is to expand internationally with evidence-based products that help people optimize mental performance and well-being in daily life and sports.
Work here?Claim your company
Simplify's take
What believers are saying
- Braineffect's site on 2026-11-10 promoted SLEEPMAXXING, DAILY GUT 5-in-1, and winter upgrades.
- Braineffect listed 12 open roles on 2026-11-07, signaling active hiring.
- Schwabe's 2025-03-17 majority deal and medium-term full takeover fund expansion.
What critics are saying
- Schwabe can absorb Braineffect completely after 2025-03-17, erasing founder control and autonomy.
- Braineffect depends on dm, Budni, and Amazon; retail shelf loss would crush volume quickly.
- Supplement regulation and claim enforcement threaten FOCUS and SLEEP marketing in Germany and France.
What makes Brain Effect unique
- Schwabe Group owns Braineffect majority since 2025-03-17, combining pharma quality with DTC speed.
- Braineffect sold 1 million products in 2024 across 2,500 dm and Budni stores.
- FOCUS, SLEEP, and DAILY GUT anchor a focused German wellness portfolio.
Help us improve and share your feedback! Did you find this helpful?